Sanofi is set to launch OTC Xyzal in the US

1 February 2017 - Deborah Wilkes

Archived

Sanofi Consumer Healthcare plans to launch OTC versions of the allergy medicine Xyzal (levocetirizine dihydrochloride) in the US in "Spring 2017".

Click tags below for more information on topics:

FDA

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: